Compound Detail
CHEMBL1201303
PYRVINIUM 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL1201303 |
| Name | PYRVINIUM |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | QMHSXPLYMTVAMK-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
12
Targets
20
Activities
3
Assay Types
1
PK Parameters
20
Publications
6
Known Names
1
Indications
Molecular Properties
382.5
MW (Da)
5.31
ALogP
2
HBA
0
HBD
12.1
PSA (Ų)
0.44
QED
1
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1982 |
| Availability | Discontinued |
| Chirality | Achiral |
Indications
Helminthiasis
ATC Classification
P02CX01
pyrvinium
Level 1: ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
Level 2: ANTHELMINTICS
Activity Summary
IC50 16 meas. best 8.0
EC50 3 meas. best 7.37
Kd 1 meas. best 9.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Casein kinase I isoform alpha CHEMBL2793 | Kd | 9.0 | 9.0 | 1.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 8.0 | 7.248 | 10.0 | 5 |
| Programmed cell death protein 1/Programmed cell death 1 ligand 1 CHEMBL4523993 | IC50 | 7.53 | 6.025 | 29.7 | 2 |
| HCT-116 CHEMBL394 | EC50 | 7.37 | 7.37 | 43.0 | 1 |
| SW480 CHEMBL612544 | EC50 | 7.25 | 7.25 | 56.0 | 1 |
| Androgen receptor CHEMBL1871 | IC50 | 6.72 | 6.72 | 190.0 | 1 |
| Cryptosporidium parvum CHEMBL612855 | IC50 | 6.45 | 6.45 | 354.0 | 1 |
| Molecular identity unknown CHEMBL612546 | IC50 | 6.23 | 6.23 | 592.0 | 1 |
| MCF-10A CHEMBL614321 | EC50 | 6.1 | 6.1 | 800.0 | 1 |
| Synaptojanin-1 CHEMBL4523136 | IC50 | 6.0 | 6.0 | 1000.0 | 2 |
| Synaptojanin-2 CHEMBL4523129 | IC50 | 5.9 | 5.9 | 1250.0 | 3 |
| Serine hydroxymethyltransferase, mitochondrial CHEMBL4295747 | IC50 | 5.59 | 5.59 | 2570.4 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| F | 1.0 | % | Mus musculus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 18591280 | 10.1128/aac.00207-08 | Cryptosporidium parvum | 8 |
| 37468498 | 10.1038/s41467-023-40064-9 | Histamine H1 receptor | 3 |
| 33636537 | 10.1016/j.ejmech.2021.113268 | Unchecked | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Gamma-aminobutyric acid receptor subunit alpha-1 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Nuclear receptor subfamily 1 group I member 2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Peroxisome proliferator-activated receptor gamma | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Progesterone receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2B | 2 |
| 37196547 | 10.1016/j.ejmech.2023.115465 | Programmed cell death protein 1/Programmed cell death 1 ligand 1 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| 31769984 | 10.1021/acs.jmedchem.9b01252 | Unchecked | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Cannabinoid receptor 1 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2A | 2 |
| 18591280 | 10.1128/aac.00207-08 | HCT-8 | 2 |
| 33636537 | 10.1016/j.ejmech.2021.113268 | Casein kinase I isoform alpha | 1 |
Data from ChEMBL 36 via Core Engine